Bone turnover markers: Defining a therapeutic target

被引：10

作者：

Chubb, S. A. Paul ^{[1
,2
,3
]}

Byrnes, Elizabeth ^{[3
]}

Manning, Laurens ^{[1
]}

Golledge, Jonathan ^{[4
]}

Ebeling, Peter R. ^{[5
]}

Flicker, Leon ^{[1
]}

Yeap, Bu B. ^{[1
,6
]}

Vasikaran, Samuel D. ^{[2
,3
]}

机构：

[1] Univ Western Australia, Sch Med & Pharmacol, Nedlands, WA 6009, Australia

[2] Univ Western Australia, Sch Pathol & Lab Med, Nedlands, WA 6009, Australia

[3] PathWest Lab Med WA, Perth, WA, Australia

[4] James Cook Univ, Coll Med & Dent, Townsville, Qld, Australia

[5] Monash Univ, Sch Clin Sci, Dept Med, Clayton, Vic 3800, Australia

[6] Fiona Stanley Hosp, Dept Endocrinol & Diabet, Murdoch, WA, Australia

来源：

CLINICAL BIOCHEMISTRY | 2017年 / 50卷 / 03期

基金：

英国医学研究理事会;

关键词：

P1NP; Treatment target; Fracture risk reduction; FRACTURE RISK; RISEDRONATE; RESORPTION; REDUCTION;

D O I：

10.1016/j.clinbiochem.2016.09.010

中图分类号：

R446 [实验室诊断]; R-33 [实验医学、医学实验];

学科分类号：

100118 [医学信息学]; 100208 [临床检验诊断学];

摘要：

引用

页码：162 / 163

页数：2

共 9 条

[1]

Bell K., 2016, J BONE MINER RES

[2]

Bone turnover markers: Defining a therapeutic target [J].

Brown, Jacques P. .

CLINICAL BIOCHEMISTRY, 2016, 49 (7-8) :527-528

[3]

Comparison of clinical cut-points and treatment targets for urine NTX and plasma βCTX-I in osteoporosis [J].

Chubb, S. A. Paul ;

Mandelt, Christine ;

Vasikaran, Samuel .

CLINICAL BIOCHEMISTRY, 2016, 49 (7-8) :529-533

[4]

Reference Intervals for Bone Turnover Markers and Their Association With Incident Hip Fractures in Older Men: The Health In Men Study [J].

Chubb, S. A. Paul ;

Byrnes, Elizabeth ;

Manning, Laurens ;

Beilby, John P. ;

Ebeling, Peter R. ;

Vasikaran, Samuel D. ;

Golledge, Jonathan ;

Flicker, Leon ;

Yeap, Bu B. .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2015, 100 (01) :90-99

[5]

Relationship of early changes in bone resorption to the reduction in fracture risk with risedronate [J].

Eastell, R ;

Barton, I ;

Hannon, RA ;

Chines, A ;

Garnero, P ;

Delmas, PD .

JOURNAL OF BONE AND MINERAL RESEARCH, 2003, 18 (06) :1051-1056

[6]

Relationship of early changes in bone resorption to the reduction in fracture risk with risedronate: Review of statistical analysis - Response [J].

Eastell, Richard ;

Hannon, Rosemary A. ;

Garnero, Patrick ;

Campbell, Michael J. ;

Delmas, Pierre D. .

JOURNAL OF BONE AND MINERAL RESEARCH, 2007, 22 (11) :1656-1660

[7]

Evaluation of a fully automated serum assay for total N-terminal propeptide of type I collagen in postmenopausal osteoporosis [J].

Garnero, Patrick ;

Vergnaud, Philippe ;

Hoyle, Nicholas .

CLINICAL CHEMISTRY, 2008, 54 (01) :188-196

[8]

Establishing a Reference Interval for Bone Turnover Markers in 637 Healthy, Young, Premenopausal Women From the United Kingdom, France, Belgium, and the United States [J].

Glover, Sarah J. ;

Gall, Martin ;

Schoenborn-Kellenberger, Oliver ;

Wagener, Michael ;

Garnero, Patrick ;

Boonen, Steven ;

Cauley, Jane A. ;

Black, Dennis M. ;

Delmas, Pierre D. ;

Eastell, Richard .

JOURNAL OF BONE AND MINERAL RESEARCH, 2009, 24 (03) :389-397

[9]

Response of bone turnover markers to three oral bisphosphonate therapies in postmenopausal osteoporosis: the TRIO study [J].

Naylor, K. E. ;

Jacques, R. M. ;

Paggiosi, M. ;

Gossiel, F. ;

Peel, N. F. A. ;

McCloskey, E. V. ;

Walsh, J. S. ;

Eastell, R. .

OSTEOPOROSIS INTERNATIONAL, 2016, 27 (01) :21-31

← 1 →